| Pharmaceutical active ingredients: |
| Bamifylline Hydrochloride |
| Available forms, composition and doses of Bami-Med: |
| N / A |
| Bami-Med medical category: |
| Human:Selective adenosine A1 receptor antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03DA08 - Bamifylline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Permamed |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lotanal | Bamethan Sulfate; Propyphenazone; Scopolamine Butylbromide | Boehringer Ingelheim |
| Flaval | Bamethan; Diclofenac; Esculoside | Cetus Laboratorios |
| Vefluxan | Bamethan; Troxerutin | Sanofi-Aventis |
| Airest | Bamifylline Hydrochloride | Caber Farmaceutici |
| Bamifix | Bamifylline Hydrochloride | Chiesi; Farmalab Industrias Quimicas e Farmaceuticas |
| Bamixol | Bamifylline Hydrochloride | Pulitzer Italiana |
| Briofil | Bamifylline Hydrochloride | Teofarma |
| Trentadil | Bamifylline Hydrochloride | Celltech; Nycomed; UCB Pharma |
| Soventol C | Bamipine Hydrochloride; Levopropylhexedrine Hydrochloride | Abbott; Nordmark Arzneimittel |
| Soventol | Bamipine Lactate | Abbott; Dr. Rentschler Arzneimittel; Knoll; Medice Arzneimittel Putter; Nicholas Piramal; Oramon Arzneimittel; Vianex |